Supplementary MaterialsAdditional file 1: Overview of the countries included in the study. the international guidelines were selected by the majority of the 34 countries studied with the CUDC-907 supplier exception of adenosine diphosphate receptor inhibitors which appeared on less than half of the NEMLs studied (41% of countries). The total number of essential medicines CUDC-907… Continue reading Supplementary MaterialsAdditional file 1: Overview of the countries included in the